News > Indian Billionaires Bet Big on Head Start in Coronavirus Vaccine Race

Indian Billionaires Bet Big on Head Start in Coronavirus Vaccine Race

The Serum Institute, which is exclusively controlled by a small and fabulously rich Indian family, is doing what a few other companies in the race for a vaccine are doing: mass-producing hundreds of millions of doses of a vaccine candidate that is still in trials and might not even work.

But if it does, Adar Poonawalla, Serum’s chief executive and the only child of the company’s founder, will become one of the most tugged-at men in the world.